Disc Medicine Cash Flow Statement
NASDAQ: IRONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
62.06+1.29 (+2.12%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Disc Medicine free cash flow
In fiscal 2025, Disc Medicine generated -$180.4 million of operating cash flow and spent $933,000 on capital expenditures. That left free cash flow of -$181.3 million.
Summary generated from market data by MetaCap's automated system. Methodology
Disc Medicine cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Net Income | -212.18M | -109.36M | -76.43M | -46.83M | -35.97M | -40.84M |
| Net Income growth (YoY) | — | — | — | — | — | — |
| Depreciation & Amortization | 281.00K | 156.00K | 100.00K | 89.00K | 32.00K | 322.00K |
| Stock-Based Compensation | 34.34M | 16.82M | 5.53M | 2.09M | 507.00K | 983.00K |
| Change in Working Capital | -7.85M | -3.11M | -1.73M | 2.09M | 2.79M | -2.41M |
| Operating Cash Flow | -180.39M | -93.93M | -73.46M | -42.25M | -27.53M | -32.71M |
| Capital Expenditures | -933.00K | -505.00K | -89.00K | -151.00K | -68.00K | -22.00K |
| Investing Cash Flow | -394.30M | -292.33M | -89.00K | -151.00K | -68.00K | -22.00K |
| Debt Issued | 0 | 28.99M | 0 | — | — | — |
| Financing Cash Flow | 473.41M | 218.31M | 239.38M | 148.98M | 89.93M | 34.25M |
| Net Change in Cash | -101.28M | -167.94M | 165.83M | 106.58M | 62.33M | 1.52M |
| Free Cash Flow | -181.33M | -94.43M | -73.55M | -42.40M | -27.60M | -32.73M |
This table shows 6 annual periods of Disc Medicine's cash flow statement, from FY 2025 back to FY 2020, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow IRON's reporting calendar. What is a cash flow statement?